Dr. Neena Passi, MD

Dr. Passi practices at Parkland Memorial Hospital in Dallas, Texas, part of Parkland Health.

Dr. Passi's NPI, 1053725093, was assigned on June 18, 2014. Dr. Passi graduated from George Washington University School of Medicine and Health Sciences in 2014. Dr. Passi holds Texas license T1507.

Dr. Passi's primary practice is Parkland Memorial Hospital, at 5200 Harry Hines Blvd, Dallas, TX 75235 in Dallas County. The practice phone is (214) 590-8000.

Dr. Passi's primary practice is Parkland Memorial Hospital in Dallas, Texas, part of Parkland Health. Dr. Passi is also affiliated with William P. Clements Jr. University Hospital. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Passi to 1 more clinical lab and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Passi practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Passi's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Passi is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Passi's licenses on file in 2 states: Texas and Pennsylvania.

Dmand AI lists aneurysm, atrial fibrillation and flutter, cardiac arrhythmia, chronic hypertension, circulation problems, coronary artery disease, heart attack and heart blockage among the conditions Dr. Passi treats.

CMS data shows 1,303 Medicare services from Dr. Passi across 14 procedure codes in 2024, for 907 Medicare patients. Medicare paid $61,186 for them.

CMS counts 907 Medicare patients who saw Dr. Passi in 2024. The largest group is 65 to 74, with 393 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.28, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Passi's median patient age at 64, with 53% women.

In 2024, Dr. Passi wrote 2,792 Medicare Part D claims for 384 patients. 83% of them were for generic drugs. CMS names the drug for 2,532 of them, across 33 drugs with 11 or more claims each, at $482,299 in total drug cost. In 2023, CMS named 1,884 claims across 31 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Passi for performance year 2024, reported as part of a group. Dr. Passi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Passi as offering telehealth.

Dmand AI links 5 papers to Dr. Passi, published from 2007 to 2021. The most frequent topics are Cell Line, Tumor and Gene Expression Regulation, Neoplastic. Dr. Passi has published most often in Cancer Biol Ther. Dr. Passi's most frequent co-authors are Archna Bajaj, MD, Ajay Kohli, MD and Taher Modarressi, MD.

CMS Open Payments shows 10 general payments to Dr. Passi from 6 drug and device companies from 2017 to 2019. Food and beverage make up the largest share, 89% of the total. Boston Scientific Corporation paid the most, $254.

Dr. Passi graduated from George Washington University School of Medicine and Health Sciences in 2014. Dr. Passi is a member of ACC.

Dr. Passi is in network with 20 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.